Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Application of reagent for restraining or reducing TG2 gene expression in preparation of tumor radiotherapy sensitivity-enhancing medicine

A tumor radiotherapy and gene expression technology, applied in the direction of anti-tumor drugs, drug combinations, pharmaceutical formulations, etc., can solve the problems of no one reporting

Inactive Publication Date: 2018-05-18
SECOND MILITARY MEDICAL UNIV OF THE PEOPLES LIBERATION ARMY
View PDF1 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] However, the application of inhibiting TG2 gene in the preparation of tumor radiosensitizing drugs has not been reported at home and abroad.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of reagent for restraining or reducing TG2 gene expression in preparation of tumor radiotherapy sensitivity-enhancing medicine
  • Application of reagent for restraining or reducing TG2 gene expression in preparation of tumor radiotherapy sensitivity-enhancing medicine
  • Application of reagent for restraining or reducing TG2 gene expression in preparation of tumor radiotherapy sensitivity-enhancing medicine

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0030] (1) Cell culture: A549 cells were cultured in DMEM medium containing 10% fetal bovine serum; the cells were placed at 37°C, 5% CO 2 Cultured in an incubator, subcultured every 2-3 days, and the cells in the logarithmic growth phase were used for experiments.

[0031] (2) Cell transfection: The day before transfection, the cells were digested with trypsin, counted, inoculated in a 6-well plate at an appropriate density, and placed in CO 2 Cultivate overnight in an incubator, so that the confluence of the cells on the day of transfection is 70%-90%. Avoid antibiotics during plating and transfection.

[0032] Preparation of transfection solution: The dosage ratio of plasmid: Lipofectamine3000 is 1 μg / well: 1.5 μl / well. Add 250 μl Opti-MEM medium to 500ng / well DNA and 5 μl / well P3000 and mix well, let it stand at room temperature for 5 minutes, and set aside; add 3.75 μl / well Lipofectamine3000 to 250 μl / well Opti-MEM medium, mix well, let stand at room temperature for 5 m...

Embodiment 2

[0035] (1) Cell culture and cell transfection are the same as in Example 1;

[0036] (2) Cell clone formation method: Take A549 cells in logarithmic growth phase and A549 cells transfected with TG2siRNA and NC sequence for 72 hours, and inoculate different numbers of cells into six-well plates according to different irradiation dose requirements (0,2,4, The number of cells inoculated with 8Gy dose was 200, 400, 800 and 1600, respectively). The three groups of cells were irradiated with different doses (0-8Gy) of γ-rays at the same time, and continued until the cell clones visible to the naked eye appeared in the culture dish, and the culture was terminated. The medium was discarded, washed twice with PBS, fixed with anhydrous methanol for 30 minutes, stained with Gimsa stain for 30 minutes, rinsed with running water, dried and counted to calculate the cell survival rate. The result is as figure 2 As shown, with the increase of irradiation dose, the cell death rate of A549 c...

Embodiment 3

[0038] (1) Cell culture and cell transfection are the same as in Example 1;

[0039] (2) Cell apoptosis detection by flow cytometry: A549 cells in the logarithmic growth phase and A549 cells transfected with TG2siRNA72h and NC sequences (1×10 5 / mL) were inoculated into six-well plates, and three groups of cells were given 8Gy 60 After irradiating with Coγ-rays and continuing to culture for 24 hours, the cells were digested with EDTA-free trypsin, washed three times with PBS after centrifugation at 1500 rpm for 5 minutes, and cell apoptosis was detected by flow cytometry after double staining with AnnexinV-FITC and PI. The result is as image 3 As shown, the apoptosis rate of A549 cells transfected with TG2siRNA was significantly higher than that of the normal A549 cell group and the A549 group transfected with NC.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to the field of gene medicine, in particular to application of a reagent for restraining or reducing TG2 gene expression in preparation of tumor radiotherapy sensitivity-enhancing medicine, and provides novel application of a TG2 gene and the reagent for restraining or reducing TG2 gene expression. The radiosensitivity of tumor cells can be effectively improved.

Description

technical field [0001] The invention relates to the field of gene medicine, specifically, the application of a reagent for inhibiting or down-regulating the expression of TG2 gene in the preparation of tumor radiotherapy sensitization medicine. Background technique [0002] Lung cancer is one of the most common malignant tumors in my country. According to the results of the cause of death survey of Chinese residents, the mortality rate of lung cancer increased by nearly 1.5 times in the 20 years from the mid-1970s to the early 1990s, making it the fastest-growing malignant tumor. Lung cancer generally refers to cancers of the lung parenchyma, usually excluding other mesodermal tumors of pleural origin, or other malignancies such as carcinoids, malignant lymphomas, or tumors that have metastasized from other sources. Lung cancer accounts for 90-95% of lung parenchymal malignancies. In the past 50 years, the incidence and mortality of lung cancer in many countries in the worl...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K45/00A61K31/713A61P35/00
CPCA61K45/00A61K31/713
Inventor 高福蔡建明杨彦勇雷霄刘哲崔建国李百龙陈媛媛张沛许洋郭佳铭曲红金刘蕾
Owner SECOND MILITARY MEDICAL UNIV OF THE PEOPLES LIBERATION ARMY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com